Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

California Doctor Faces Murder Trial in 3 Drug Deaths

By Drug Discovery Trends Editor | September 1, 2015

This March 16, 2012 file photo, Dr Lisa Tseng cries during her arraignment in court in Los Angeles. Attorneys are set to deliver opening statements Monday, Aug. 31, in the trial of Tseng, charged with murder the deaths of three young men who overdosed on prescription pain killers. Tseng has pleaded not guilty to three counts of second-degree murder. She could face up to life in prison if convicted on all the charges against her. (AP Photo/Nick Ut)Even after several patients died of overdoses, a California doctor charged in their deaths kept passing out prescriptions for powerful painkillers in appointments that lasted as little as three minutes, often without physical exams and despite red flags that she could be feeding addictions, a prosecutor told jurors Monday.

A defense attorney for Dr. Hsiu-Ying “Lisa” Tseng countered that some of those patients were suicidal, others were using the prescriptions to party, and all took well over the recommended dosage.

The lawyer painted Tseng as a somewhat naive doctor who was soft-hearted and never thought her patients would abuse her prescriptions.

The conflicting portraits drawn in opening statements marked the beginning of Tseng’s murder trial, a rare charge for a doctor for prescribing drugs. Tseng, 45, could face up to life in prison if convicted.

Prosecutor John Niederman told jurors that a coroner notified Tseng of her first patient death by overdose in September 2007, two days after he had gotten prescriptions from her for oxycodone, Xanax, and Soma.

The next patient died six months later. Jurors were shown a picture of his body, lying face-down in his bed.

One patient overdosed in Tseng’s own clinic, Niederman said.

“The defendant was repeatedly notified by law enforcement that her patients were dying on her,” Niederman told jurors. “The evidence will show that during this period of time, the defendant’s practice of prescribing did not change at all.”

Niederman said jurors should find Tseng guilty of second-degree murder in the deaths of three of her patients, all young men. He said 12 of Tseng’s patients died in all, but only three were the subject of murder charges because other factors were involved in the other deaths.

Tseng’s attorney, Tracy Green, told jurors that her client, who came to the U.S. from Taiwan when she was 15, was a specialist in infectious diseases when her family convinced her to join her husband’s family practice because it was safer and she would be closer to home and her two children.

Tseng wasn’t trained in pain management and was trying her best to treat her patients, Green said.

“She was trying to help … She wasn’t callous or indifferent,” she said. “Lisa Tseng did not murder those three men.”

Green said the deaths were tragic but the case is “bigger than Lisa Tseng,” and other factors – the pharmacists who filled the prescriptions and drugs the men obtained from other doctors and on the street – also played roles.

“It’s difficult to place all of the responsibility on Lisa Tseng,” Green said.

The Drug Enforcement Administration said Tseng wrote more than 27,000 prescriptions over a three-year period starting in January 2007 – an average of 25 a day. She operated a storefront medical clinic with her husband in the Los Angeles suburb of Rowland Heights.

The three murder charges stem from the overdose deaths of patients in 2009, including 21-year-old Joey Rovero, a senior at Arizona State University who grew up in the San Francisco Bay Area suburb of San Ramon.

Rovero’s mother, April Rovero, said her son never had any problems with addiction and once walked 2 miles home in the middle of the night after drinking beer with his buddies instead of driving.

“My son was a victim that needs to be represented,” April Rovero told The Associated Press. “When this happens to a child or a sibling, my experience is it changes your life irrevocably, forever. It’s not something you get over.”

Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50